ArticleDermatologic therapy2022

Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID-19 vaccine: Successful treatment with ustekinumab and acitretin.

Shirley Braga Lima Gamonal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.